Harhoff, Dietmar; Reitzig, Markus - C.E.P.R. Discussion Papers - 2002
We analyse the determinants of opposition to biotechnology and pharmaceutical patents granted by the European Patent Office between 1978–96. Opposition can be considered an early form of patent validity challenge suit. In our sample, 8.6% of the patents are attacked in opposition proceedings....